Blaze TrendsJun 6
Eli Lilly's $3.83 billion acquisition of Curevo, LimmaTech Biologics, and Vaccine Company signals a strategic pivot into infectious disease prevention. The buyout includes a shingles candidate positioned to challenge GSK's Shingrix. #EliLilly #Biotech #Investing #PharmaNews
https://blazetrends.com/eli-lilly-targets-gsk-and-long-term-disease-with-3-8-billion-vaccine-acquisition-spree/?fsp_sid=27829
Eli Lilly targets GSK and long-term disease with $3.8 billion vaccine acquisition spree

Flush with unprecedented cash from its dominant diabetes and obesity GLP-1 franchise, Eli Lilly is aggressively acquiring its way into the infectious disease sector to secure long-term revenue. The pharmaceutical company is finalizing the $3.83 billion acquisition of three clinical-stage vaccine developers: Curevo, LimmaTech Biologics, and Vaccine Company. The acquisitions, officially announced on May 26,

Blaze Trends
CinqueW NewsMay 27
ANTITRUST Biogen probed by Italy over MS drug competition cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews

Biogen probed by Italy over MS...
Biogen probed by Italy over MS drug competition

Italy probes Biogen over alleged attempts to block Sandoz’s MS biosimilar and limit competition in natalizumab drugs.

sabamirzaMay 7

Bayer Stock jumps after $2.45B Perfuse deal reshapes future pharmaceutical innovation strategy globally.

#BayerStock #PharmaNews #StockMarket #HealthcareInvesting

https://meyka.com/blog/bayer-stock-may-7-245b-perfuse-deal-signals-pharma-shift-0705/

Bayer Stock May 7: $2.45B Perfuse Deal Signals Pharma Shift | Meyka

Bayer acquires Perfuse Therapeutics for $2.45B to strengthen ophthalmology portfolio with PER-001 drug candidate, addressing Eylea patent risks.

Abasa LenseFeb 24

Big Pharma’s Hidden Power Shift: DHL Expands Global Drug Delivery Empire

Global logistics giant DHL is expanding its pharmaceutical airfreight network — and this isn’t just about faster shipping.

Behind the move is a trillion-dollar power play to control how medicines travel worldwide. From vaccines to biotech drugs, whoever dominates pharma logistics gains massive influence over global healthcare supply chains.

#DHL #pharmanews

Tycoon WorldFeb 12

ENTOD Pharmaceuticals Joins Global Efforts to Tackle Preventable Childhood Blindness

#TycoonWorld #ChildhoodBlindness #PreventableBlindness #RightToSight #EyeHealth #PaediatricOphthalmology #VisionCare #ROPPrevention #RetinopathyOfPrematurity #GlobalHealth #PublicHealth #SDG3 #HealthForAll #ChildHealth #HealthcareInnovation #PharmaNews #ENTODPharmaceuticals #Ophthalmology #EarlyScreening

https://tycoonworld.in/entod-pharmaceuticals-joins-global-efforts-to-tackle-preventable-childhood-blindness/

ENTOD Pharmaceuticals Joins Global Efforts to Tackle Preventable Childhood Blindness – Tycoon World

New Delhi, 12th February, 2026: ENTOD Pharmaceuticals, a global ophthalmology-focused pharmaceutical company, reaffirmed its commitment to preventing

Tycoon World
Mathrubhumi EnglishJan 21
CDSCO flags 167 drug samples as Not of Standard Quality (NSQ) in December, including spurious drugs. Learn about the latest drug safety alerts and regulatory actions. https://english.mathrubhumi.com/news/india/cdsco-drug-quality-alert-december-h3iajdl6?utm_source=dlvr.it&utm_medium=mastodon #CDSCO #DrugSafety #NSQDrugs #MedicineQuality #PharmaNews
Wisdom4theblindJan 20

New lawsuits claim Ozempic and other GLP-1 drugs may be linked to NAION-related vision loss. Patients allege unexpected blindness risks. Read More Here: https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/
#Ozempic #GLP1 #NAION #VisionLoss #DrugSafety #PharmaNews

https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/

Ozempic Blindness Lawsuits: Legal Claims Allege GLP-1 Drugs Linked to NAION Vision Loss | JD Supra

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight...

JD Supra
vaarthahindiOct 9, 2025
Latest Hindi News: Coldrif scandal: Srsen Pharma director Ranganathan arrested, investigation intensified
https://hindi.vaartha.com/national/coldrif-scandal-srsen-pharma-director-ranganathan-arrested-investigation-intensified/66242/
#ColdRifScandal #SresanPharma #RanganathanArrested #PharmaScandal #ToxicCoughSyrup #ChildrensDeaths #CoughSyrupTragedy #SresanPharmaRaid #DrugSafety #PharmaInvestigation #MadhyaPradeshNews #TamilNaduCrime #ChennaiNews #PharmaNews #BreakingNews
Latest Hindi News : कोल्ड्रिफ कांड : स्रसेन फार्मा के डायरेक्टर रंगनाथन गिरफ्तार, जांच तेज

एक फार्मास्युटिकल कंपनी स्रसेन फार्मा की ओर से निर्मित जहरीले कोल्ड्रिफ कफ सीरप ने मध्य प्रदेश में कम से कम 20 बच्चों की जान ले ली।

Hindi Vaartha
The Urban HeraldSep 4, 2025
Pfizer CEO praises Trump administration amid ongoing pharma industry shifts, while RFK Jr. pushes for major CDC reforms. Meanwhile, Novartis seals a massive $5.2 billion deal, shaking up global healthcare markets. Big moves in pharma today! 💊🌍 #PharmaNews #HealthInnovation
Hacker NewsAug 15, 2025

Time to End Roundtripping by Big Pharma

https://www.cfr.org/blog/time-end-roundtripping-big-pharma

#HackerNews #Time #to #End #Roundtripping #by #Big #Pharma #BigPharma #EndRoundtripping #Healthcare #Reform #PharmaNews

Time to End Roundtripping by Big Pharma

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

Council on Foreign Relations